.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cerilliant
Harvard Business School
Julphar
Deloitte
Novartis
Baxter
US Department of Justice
UBS
Daiichi Sankyo
Fuji

Generated: September 25, 2017

DrugPatentWatch Database Preview

Hq Spclt Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for HQ SPCLT PHARMA, and when can generic versions of HQ SPCLT PHARMA drugs launch?

HQ SPCLT PHARMA has six approved drugs.

There are four US patents protecting HQ SPCLT PHARMA drugs.

There are forty patent family members on HQ SPCLT PHARMA drugs in twenty-five countries.

Summary for Applicant: Hq Spclt Pharma

Patents:4
Tradenames:9
Ingredients:6
NDAs:6
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE DOUBLE STRENGTH IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-002Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Hq Spclt Pharma
DEXMEDETOMIDINE HYDROCHLORIDE
dexmedetomidine hydrochloride
SOLUTION;IV (INFUSION)206628-001Oct 21, 2015RXYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
ESMOLOL HYDROCHLORIDE IN PLASTIC CONTAINER
esmolol hydrochloride
SOLUTION;INTRAVENOUS205703-001Apr 7, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988APRXYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
MAGNESIUM SULFATE IN DEXTROSE 5% IN PLASTIC CONTAINER
magnesium sulfate
INJECTABLE;INJECTION207349-001Mar 2, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 1984DISCNYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992APRXYesNo► Subscribe► Subscribe► Subscribe
Hq Spclt Pharma
LINEZOLID
linezolid
SOLUTION;IV (INFUSION)207001-002Jul 7, 2017APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Hq Spclt Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 1984► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL-AQ
cisplatin
INJECTABLE;INJECTION018057-003Jul 18, 1984► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt Pharma
CISPLATIN
cisplatin
INJECTABLE;INJECTION018057-004Nov 8, 1988► Subscribe► Subscribe
Hq Spclt Pharma
PLATINOL
cisplatin
INJECTABLE;INJECTION018057-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
Hq Spclt Pharma
TAXOL
paclitaxel
INJECTABLE;INJECTION020262-001Dec 29, 1992► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Hq Spclt Pharma Drugs

Country Document Number Estimated Expiration
World Intellectual Property Organization (WIPO)2014143845► Subscribe
Spain2272720► Subscribe
China105263809► Subscribe
China1455669► Subscribe
Russian Federation2002132189► Subscribe
Australia2002309475► Subscribe
Australia2014228155► Subscribe
Japan2010024249► Subscribe
World Intellectual Property Organization (WIPO)02076446► Subscribe
Slovakia288113► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Hq Spclt Pharma Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012 00035Denmark► SubscribePRODUCT NAME: ET KOMBINATIONSPRODUKT AF NAPROXEN OG ESOMEPRAZOL MAGNESIUM TRIHYDRAT; NAT. REG. NO/DATE: 49583 20120327; FIRST REG. NO/DATE: GB PL 17901/0263-001 20101105
2014000065Germany► SubscribePRODUCT NAME: PACLITAXEL ALS AN ALBUMIN GEBUNDENE NANOPARTIKEL-FORMULIERUNG; REGISTRATION NO/DATE: K(2013)9835 20131220
2014022Lithuania► SubscribePRODUCT NAME: PACLITAXELUM; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220
C/GB01/006United Kingdom► SubscribePRODUCT NAME: ESOMEPRAZOLE AS MAGNESIUM TRIHYDRATE; REGISTERED: SE 15945 20000310; SE 15946 20000310; UK PL 17901/0068-0069 20000727
2012000017Germany► SubscribePRODUCT NAME: ASPIRIN UND ESOMEPRAZOL - MAGNESIUM-TRIHYDRAT; NAT. REGISTRATION NO/DATE: 81047.00.00 20110930 FIRST REGISTRATION: PORTUGAL 5402359 5402367 5402375 20110812
2004004Lithuania► SubscribePRODUCTNAME: LINEZOLIDUM - (S)-N-[[3-FLUOR-4-(4-MORFOLINIL)FENIL]-2-OKSO-5-OKSAZOLIDINIL]METIL]-ACETAMIDAS
00673Netherlands► SubscribePRODUCT NAME: PACLITAXEL, GEFORMULEERD ALS ALBUMINE-GEBONDEN NANODEELTJES; REGISTRATION NO/DATE: EU/1/07/428/001-002 20131220
2004004,C0717738Lithuania► SubscribePRODUCT NAME: LINEZOLIDUM ((S)-N-((3-(3-FLUOR-4-(4-MORFOLINIL)FENIL)-2-OKSO--5-OKSAZOLIDINIL)METIL)-ACETAMIDAS); REGISTRATION NO/DATE: 02/8199/2 20030313
00483Netherlands► SubscribePRODUCT NAME: NAXOPREN EN ESOMEPRAZOL ALS MAGNESIUMTRIHYFRAAT; NAT. REGISTRATION NO/DATE: RVG 106235 20101118; FIRST REGISTRATION: PL 17091/0263 - 0001 20110524
/2014Austria► SubscribePRODUCT NAME: PACLITAXEL, DAS ALS ALBUMIN GEBUNDENE NANOPARTIKEL FORMUIERT IST.; REGISTRATION NO/DATE: EU/1/07/428 (MITTEILUNG) (GEAENDERT DURCH C(2013) 9835) 20131230
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Teva
Merck
Federal Trade Commission
Colorcon
Covington
Chubb
Baxter
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot